Does Dr. DAVID DE ANGEL SOLA have financial conflicts of interest?

Dr. DAVID DE ANGEL SOLA (M.D.) has received a total of $1,503 in pharmaceutical and medical device industry funding between 2021 and 2025. This includes $1,503 in personal promotional payouts (consulting, meals, travel) and $0 in clinical research grants. Financial ties do not automatically imply conflict of interest, but are disclosed under the Sunshine Act.

Which pharmaceutical companies pay Dr. DAVID DE ANGEL SOLA?

According to CMS Open Payments data, Dr. DAVID DE ANGEL SOLA received funding from JAZZ PHARMACEUTICALS ($447), HARMONY BIOSCIENCES ($327), and GENZYME CORPORATION ($185).

Does Dr. DAVID DE ANGEL SOLA receive research grants or speaking fees?

Dr. DAVID DE ANGEL SOLA has received $1,503 in general promotional payments (such as consulting honoraria, meals, and speaking fees) and $0 in clinical research grants.

DR. DAVID DE ANGEL SOLA

M.D.Real-Time Hydrated

Specialty: Pediatrics, Sleep Medicine

Practice Location: SAN JUAN, PR 00921

NPI Number: 1467707570

LIFETIME INDUSTRY VALUE

$1,503

2021 – 2025 Cumulative

Conflict of Interest Analysis

Dr. DE ANGEL SOLA is a verified Pediatrics, Sleep Medicine practitioner based in SAN JUAN, PR.

Between 2021 and 2025, Dr. DE ANGEL SOLA had an overall industry promotional and research financial footprint of $1,503 as recorded in the federal CMS Open Payments database.

$1,503 was received in general payments, which include consultation fees, travel expenses, honoraria, and sponsored meals.
$0 was allocated to sponsored clinical trials and medical research activities.

Dr. DE ANGEL SOLA's primary funding source is JAZZ PHARMACEUTICALS, which accounts for $447 (representing 29.7% of overall industry footprint).

Data coverage: 2021 – 2025 · Source: CMS Open Payments · CMS publishes each year's data around June 30 of the following year.

Payout Trend Over Time

General Payments

Research Funding

Top Funding Entities

Pharmaceutical & Device Manufacturers making direct payments

JAZZ PHARMACEUTICALS

Rank 1

$447

29.7%

HARMONY BIOSCIENCES

Rank 2

$327

21.8%

GENZYME CORPORATION

Rank 3

$185

12.3%

Itemized Transaction Archives

Direct live query to Socrata CMS Open Payments API (Bypasses local DB)

Year:

2025

Filter < $250

Click "Load Live Logs" to query the federal Open Payments registry directly.

Frequently Asked Questions

Answers compiled using federal transparency disclosure records under the Sunshine Act.